SCHEMBL20204887

SCHEMBL20204887

Cc1cnn(-c2cc(F)ccc2F)c1

nearest known ligand 0.48

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
RXRA P19793 4/20 0.48
GRIN1 Q05586 4/20 0.48
GRIN2B Q13224 4/20 0.48
SCD O00767 2/20 0.44
TDO2 P48775 2/20 0.44
L3MBTL1 Q9Y468 2/20 0.40
KDM4E B2RXH2 1/20 0.40
MAPT P10636 1/20 0.40
MAPK1 P28482 1/20 0.40
NPSR1 Q6W5P4 1/20 0.40
ALDH1A1 P00352 3/20 0.38
KAT6A Q92794 3/20 0.37
MEN1 O00255 1/20 0.36
CYP1A2 P05177 1/20 0.36
CYP2C9 P11712 1/20 0.36
KMT2A Q03164 1/20 0.36
NPC1 O15118 1/20 0.35
RAB9A P51151 1/20 0.35
CYP46A1 Q9Y6A2 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10264757 0.86 TDO2 (0.44) RXRAGRIN1GRIN2BSCDTDO2
SCHEMBL21478371 0.79 RXRA (0.44) RXRAGRIN1GRIN2BL3MBTL1KDM4E
SCHEMBL5546869 0.79 GRM4 (0.48) TDO2L3MBTL1KDM4EMAPTMAPK1
SCHEMBL122101 0.76 MTOR (0.38) RXRAGRIN1GRIN2BTDO2L3MBTL1
SCHEMBL12349894 0.74 GRM4 (0.43) TDO2L3MBTL1KDM4EMAPTMAPK1
SCHEMBL10264239 0.74 KAT6A (0.48) RXRAGRIN1GRIN2BTDO2L3MBTL1
SCHEMBL14320344 0.73 TDO2 (0.49) SCDTDO2L3MBTL1KDM4EMAPT
SCHEMBL12988811 0.73 TDO2 (0.41) TDO2L3MBTL1KDM4EMAPTMAPK1
SCHEMBL3143610 0.72 NPC1 (0.50) RXRAGRIN1GRIN2BL3MBTL1KDM4E
SCHEMBL17180077 0.72 CYP46A1 (0.46) TDO2L3MBTL1KDM4EMAPTMAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3544613-B1 GSK-3 INHIBITORS BRISTOL MYERS SQUIBB CO (US) 2021-06-09 EP disclosed
WO-2018098412-A1 GSK-3 INHIBITORS BRISTOL-MYERS SQUIBB COMPANY (US) 2018-05-31 WO disclosed